Linkage Biosciences is a molecular diagnostics company developing products that will dramatically improve and expedite complex genetic testing. Our initial focus is on diagnostic products for stem cell and solid organ transplantation where our proprietary technology will have an immediate impact. We have assembled an outstanding management team and scientific advisory board who are well known experts in their respective fields. Please stay tuned for further announcements.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 07/31/07 | Seed | 1M | All Pro Quality painting. provides the very best local painting services for residential and Commercial., Fishbowl Labs Incubator | Unknown |
| 02/01/09 | Series A | 2M | Unknown |
People
Rebecca Bishop (Board Member)
Jeffrey Krauss (Board Member)
Michael Eck (Board Member)
Constance McKee (Board Member)
Zachary Antovich (President/CEO)
News
LinkageBio connects $2M for organ transplant typing
February 5, 2009 9:28 am
San Francisco biotech firm Linkage Biosciences announced that it raised $2 million in first-round funding to commercialize its first product,… Continue reading ⟩
Linkage Biosciences pulls in $1M for improved genetic tests
October 17, 2007 5:03 am
See our story on this San Francisco biotech at VentureBeat Life Sciences. Continue reading ⟩
Life sciences briefing: Tuesday, Oct. 16, 2007
October 17, 2007 5:00 am
Featured companies: Altair Therapeutics, ICyt Visionary Biosciences, Linkage Biosciences, Mendel Biotechnology, Rules-Based Medicine Mendel Biotechnology raises funds for cellulosic-energy production… Continue reading ⟩